BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 24, 2008
View Archived Issues
BMS Goes Hostile, Takes Higher Offer to ImClone Shareholders
Bristol-Myers Squibb Co. hasn't given up trying to acquire Erbitux partner ImClone Systems Inc. (BioWorld Today)
Read More
KaloBios Gets $20M Series D for Humaneered Antibodies
Read More
Addressing Publication Bias May Have Unintended Consequences
Read More
FTC: System-Gaming Loopholes Could Impair Any FOB Bill
Read More
Cellerant $13.5M Contract Will Fund Lead Program
Read More
Other News To Note
Read More
Clinic Roundup
Read More